NTI hosted a wide-ranging discussion on the implications of artificial intelligence technologies for nuclear and biosecurity at its Board of Directors dinner in Washington, D.C.
Amid significant advances in artificial intelligence (AI), a new NTI | bio report recommends urgent action and oversight by governments, industry, and the scientific community to reduce risks associated with AI-enabled capabilities to engineer living systems.
The DoD’s new CWMD strategy, last updated in 2014, comes at a time when longstanding norms against nuclear use are being tested.
In an editorial for Science Magazine, IBBIS Executive Director Piers Millett, argues for greater safeguards to protect the dangerous pathogens kept in labs around the world.
The paper highlights the need for renewed attention to the catastrophic effects of nuclear conflict as a crucial step toward reducing the risk of nuclear use.
Jaime Yassif called on government leaders to take urgent steps to strengthen biosafety and biosecurity policy and practices during a hearing convened by the U.S. House Select Subcommittee on the Coronavirus Pandemic.
Dr. Emily Leproust, the CEO and co-founder of Twist Bioscience, has joined the Board of Directors of the Nuclear Threat Initiative.
Co-Chair and CEO of NTI and CEO and President of the EFI Foundation Ernest J. Moniz, Executive Director of CATF Armond Cohen, and experts from NTI, EFI Foundation, and CATF briefed Managing Director and CEO of ENEC His Excellency Mohamed Al Hammadi and ENEC staff on their work promoting the responsible, sustainable, and effective expansion of nuclear energy.
NTI President and COO Joan Rohlfing called on young people to bring innovation and new strategies to manage and combat today’s nuclear threats at a recent event sponsored by the University of Pennsylvania’s Perry World House.
The International Partnership for Nuclear Disarmament Verification (IPNDV) convened its most recent working meeting in Budapest, Hungary from September 4-8, 2023.
